EUVIMEDEUVIMED entdecken
Crossref

Anti-Xa directed low-molecular-weight heparin dosing to reduce the risk of venous thromboembolism in pregnant women with inherited antithrombin deficiency

Caroline Dix, Karen Breen, Susan Robinson, Aine McCormick, Beverley J Hunt

Journal of Thrombosis and Haemostasis · 2026

DOI: 10.1016/j.jtha.2025.07.031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026. Verfasst von Caroline Dix und 4 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Thrombosis and Haemostasis, Guy's & St Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom. Electronic address:…. Hauptthemen laut MEDLINE: Venous Thromboembolism, Heparin, Low-Molecular-Weight, Antithrombin III Deficiency, Factor Xa Inhibitors. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Inherited antithrombin deficiency (ATD) is associated with a high risk of venous thromboembolism (VTE), particularly during risk periods, including pregnancy. Guidelines vary regarding thromboprophylaxis with low-molecular-weight heparin (LMWH). LMWH use in women with inherited ATD is hampered by the fact that antithrombin is the substrate for its anticoagulant effect, and therefore, larger doses of LMWH are needed. OBJECTIVES: Assess the rate of VTE in pregnant women with inherited ATD after our institution changed practice to using anti-Xa-guided LMWH in 2012. METHODS: This was a retrospective single-center cohort study of pregnant women with inherited ATD, followed from positive pregnancy test to 6 weeks postpartum. RESULTS: We identified 32 pregnancies in 17 women, 12 with type 1 and 5 with type 2 inherited ATD. Twenty-two (69%) resulted in a live birth. There were 4 cases of VTE (12.5%): 2 occurred in women prior to referral to our unit on subtherapeutic doses of LMWH; 1 in a nonadherent patient with homozygous AT Budapest; and 1 postpartum VTE in the setting of nonadherence. The median starting dose of LMWH in the whole cohort was 6250 units (96 units/kg), increasing to 16 750 units (247 units/kg) by the end of pregnancy. Antithrombin concentrate was given peripartum in 20 pregnancies. There were 4 postpartum hemorrhages (12.5%), 1 minor and 3 moderate. CONCLUSION: In this retrospective cohort study of 32 pregnancies, 12.5% of our cohort had a VTE. However, there was no VTE in those who were adherent and received anti-Xa monitored LMWH with risk-assessed use of peripartum antithrombin concentrate.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Venous ThromboembolismHeparin, Low-Molecular-WeightAntithrombin III DeficiencyFactor Xa InhibitorsAnticoagulantsPregnancy Complications, HematologicPregnancy Complications, CardiovascularHumansFemalePregnancyRetrospective StudiesAdultRisk FactorsTreatment OutcomeYoung AdultLive Birth

Stichwörter der Autor:innen

antithrombin deficiencypregnancythromboprophylaxisvenous thrombosis

Substanzen

Heparin, Low-Molecular-WeightFactor Xa InhibitorsAnticoagulants

Autor:innen und Institutionen

  • Centre for Thrombosis and Haemostasis, Guy's & St Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom. Electronic address: c.dix@alfred.org.au.
  • Centre for Thrombosis and Haemostasis, Guy's & St Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Haemostasis Laboratory, Synnovis, Guy's & St Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Centre for Thrombosis and Haemostasis, Guy's & St Thomas' National Health Service (NHS) Foundation Trust, London, United Kingdom. Electronic address: https://twitter.com/@bhwords.

Zitieren

APA

Dix, C., Breen, K., Robinson, S., McCormick, A., & Hunt, B. J. (2026). Anti-Xa directed low-molecular-weight heparin dosing to reduce the risk of venous thromboembolism in pregnant women with inherited antithrombin deficiency. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2025.07.031

Vancouver

Dix C, Breen K, Robinson S, McCormick A, Hunt BJ. Anti-Xa directed low-molecular-weight heparin dosing to reduce the risk of venous thromboembolism in pregnant women with inherited antithrombin deficiency. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2025.07.031

BibTeX
@article{Dix2026,
  author = {Dix, Caroline and Breen, Karen and Robinson, Susan and McCormick, Aine and Hunt, Beverley J},
  title = {Anti-Xa directed low-molecular-weight heparin dosing to reduce the risk of venous thromboembolism in pregnant women with inherited antithrombin deficiency},
  journal = {Journal of Thrombosis and Haemostasis},
  year = {2026},
  doi = {10.1016/j.jtha.2025.07.031}
}
Kostenlos starten →